PRICE T ROWE ASSOCIATES INC /MD/
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$100,531,000
-$71,224,740 QoQ
Shares Held
187,226
-42.9% QoQ
Ownership
0.810%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. MDGL ranks #46 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in MDGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,531,000 | 187,226 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $171,755,740 | 328,110 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $182,656,181 | 313,659 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $161,686,822 | 352,520 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $153,881,544 | 508,464 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $179,736,328 | 542,633 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $181,674,906 | 588,764 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $155,705,177 | 733,697 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $240,591,602 | 858,765 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $214,489,998 | 803,213 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $89,944,115 | 388,729 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $24,881,272 | 170,373 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,798,093 | 55,403 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,386,219 | 47,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,036,312 | 55,250 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,029,898 | 46,621 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,035,135 | 42,402 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,405,489 | 44,899 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,105,907 | 48,453 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,611,862 | 57,800 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,427,999 | 76,255 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,005,730 | 85,541 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,033,304 | 171,209 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,854,330 | 175,645 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $16,305,168 | 143,975 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,118,893 | 46,718 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||